European Medicines Agency recommends contraindication for Regranex in patients with any pre-existing cancer

View source ↗

Summary

EMA recommends contraindicating Regranex (becaplermin) in patients with any pre-existing cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Regranex (becaplermin)